A phase <scp>II</scp> study of anlotinib combined with etoposide and platinum‐based regimens in the first‐line treatment of extensive‐stage small cell lung cancer-Reference-Cited by-同舟云学术

A phase II study of anlotinib combined with etoposide and platinum‐based regimens in the first‐line treatment of extensive‐stage small cell lung cancer

Published:2022-04-07 Issue:10 Volume:13 Page:1463-1470
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Liu Chang¹²³,Liao Jiatao¹²³,Wu Xianghua¹²³,Zhao Xinmin¹²³,Sun Si¹²³,Wang Huijie¹²³,Hu Zhihuang¹²³,Zhang Yao¹²³,Yu Hui¹²³,Wang Jialei¹²³^ORCID

Affiliation:

1. Department of Thoracic Medical Oncology Fudan University Shanghai Cancer Center Shanghai China

2. Department of Oncology Shanghai Medical College, Fudan University Shanghai China

3. Institute of Thoracic Oncology Fudan University Shanghai Cancer Center Shanghai China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14414

Reference29 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Mechanisms of drugs-resistance in small cell lung cancer: DNA-related, RNA-related, apoptosis-related, drug accumulation and metabolism procedure

3. Small-cell lung cancer

4. Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data

5. Comparison of First-Line Treatments for Patients With Extensive-Stage Small Cell Lung Cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting FGFR for cancer therapy;Journal of Hematology & Oncology;2024-06-03

2. Anlotinib enhanced CD8+ T cell infiltration via induction of CCL5 improves the efficacy of PD-1/PD-L1 blockade therapy in lung cancer;Cancer Letters;2024-06

3. STING pathway as a cancer immunotherapy: Progress and challenges in activating anti-tumor immunity;Molecular Biology Reports;2024-04-05

4. The Efficacy and Safety of Anlotinib Plus Etoposide with Cisplatin/Carboplatin in the First-Line Treatment of Lung Cancer: A Phase II Clinical Study;Journal of Cancer;2024

5. Single‐cell RNA sequencing reveals immune microenvironment of small cell lung cancer‐associated malignant pleural effusion;Thoracic Cancer;2023-11-27